Marcos Milla
InvestorVenture Partner at Samsara BioCapital
San Diego, California
Writes $10M – $100M checks · typically $25M
Find your path to Marcos
331 people in our graph share verified history with Marcos — schools, employers, funds. One of them is your warm intro.
Hemant TanejaunlockedMarcos: together at Massachusetts Institute of Technology (1993)
×7Marcos: together at Massachusetts Institute of Technology
×2Marcos: together at Roche Pharmaceuticals
Marcos: together at Samsara BioCapital
About
Marcos Milla is a Venture Partner at Samsara BioCapital and serves as a Member of the Board of Patrons at Universidad Peruana Cayetano Heredia. His professional focus encompasses the discovery and development of therapeutics for immune modulation, with expertise in biochemistry, biophysics, molecular pharmacology, cell and molecular biology, protein chemistry, and molecular immunology.
Experience
- Universidad Peruana Cayetano Heredia Board of PatronsMembercurrent2023 — presentLima, Peru
- Samsara BioCapitalVenture Partnercurrent2021 — presentGreater San Diego Area
- The Milla Goni Family FoundationPresidentcurrent2020 — presentSan Diego, California, United States
- Synthorx IncChief Scientific Officer2018 — 2021Greater San Diego Area
- Synthorx IncSenior Vice President of Research2017 — 2018Greater San Diego Area
- Adaptive Biotechnologies Corp.Vice President, Therapeutics2016 — 2017
- Janssen, Pharmaceutical Companies of Johnson and JohnsonGlobal Head, Emerging Science & Innovation, Discovery Sciences2014 — 2016La Jolla, CA, USA
- Janssen, Pharmaceutical Companies of Johnson and JohnsonScientific Director and Fellow, Immunology Discovery2009 — 2014La Jolla, California
- Roche PharmaceuticalsDirector2005 — 2009
- University of Pennsylvania School of MedicineProfessor1998 — 2005
- GlaxoSmithKlineResearch Investigator1995 — 1998
- MITPost Doctoral Fellow1990 — 1993
Skills & more
Protein Chemistry61Biotechnology44Biophysics38Biochemistry83Protein-protein Interactions8Biomarker Discovery10In Vitro25Signal Transduction27Medicinal Chemistry12Immunology34Molecular Biology56Oncology12
+12 more
Drug DiscoveryCellInflammationLifesciencesGPCRsAssay DevelopmentPharmacologyLife SciencesPharmaceutical IndustryCell CultureClinical DevelopmentDrug DevelopmentLanguages English · Spanish
From Marcos's professional profile.
Deals · 1
Lumen BioscienceBoard seat
via Samsara BioCapital · filed Apr 2025 · $23M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Per SEC Form D filings.
Colleagues at Samsara BioCapital
Network1
Investors connected to Marcos in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Marcos Milla?
- Marcos Milla is a Venture Partner at Samsara BioCapital and serves as a Member of the Board of Patrons at Universidad Peruana Cayetano Heredia. His professional focus encompasses the discovery and development of therapeutics for immune modulation, with expertise in biochemistry, biophysics, molecular pharmacology, cell and molecular biology, protein chemistry, and molecular immunology.
- Where does Marcos Milla work?
- Marcos Milla is Venture Partner at Samsara BioCapital.
- What check size does Marcos Milla write?
- Marcos Milla typically writes checks of $10M – $100M.
- What boards does Marcos Milla sit on?
- Marcos Milla holds tracked board seats at Enlaza Therapeutics, Lumen Bioscience.
- Where did Marcos Milla go to school?
- Marcos Milla studied at Saint Louis University School of Medicine (PhD in Cell and Molecular Biology, Biochemistry and Molecular Biology); Duke University School of Medicine (Postdoc, Lipid biochemistry); Massachusetts Institute of Technology (JCCF Fellow, Protein chemistry and molecular genetics).
Same school
Also attended Duke University School of Medicine24
Rache SimmonsBreast Cancer Surgeon at FemHealth VenturesJeff LawsonPhysician-Scientist, Inventor, Entrepreneur, Innovator, and Investor at Swift Street CapitalJustin KleinCo-Founder and Managing Partner at Vensana CapitalAftab KheraniManaging Partner at Ajax HealthMatthew McGirtGeneral Partner at Mammoth ResearchDaniel LuoAssistant Director at Duke Capital Partners
+ 18 more
Also attended Massachusetts Institute of Technology2,000
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,994 more
Shared employers
Also worked at Synthorx Inc2
Also worked at Adaptive Biotechnologies Corp.6
Mark AdamsPartner at Two Bear CapitalJill MooneyAdvisor at Avalon BioVenturesJan BerkaProject Manager with a Focus on International Contacts at Biotech Investments S.R.OJohn StuelpnagelAdvisor at VenrockHarlan RobinsExecutive Officer at Adaptive BiotechnologiesCraig WeissmanCo-founder & CTO at Duetto
Also worked at Janssen, Pharmaceutical Companies of Johnson and Johnson56
Patrick LoerchBio Advisor at Amplify PartnersUmut EserVenture Partner at Magnetic VenturesLance BermanVenture Partner at Ysios CapitalJuan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance PartnersPatrick ForsterInvestment Analyst at The Spartan GroupMichael KalosInvestor at 82VS
)
+ 50 more
Also worked at Roche Pharmaceuticals147
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 141 more